Sex-specific regulation of IL-10 production in human adipose tissue in obesity

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,82 MB, PDF-dokument

  • Narmadha Subramanian
  • Beatriz Tavira
  • Kaisa Hofwimmer
  • Beate Gutsmann
  • Lucas Massier
  • Julie Abildgaard
  • Juul, Anders
  • Mikael Rydén
  • Peter Arner
  • Jurga Laurencikiene

Background: Obesity-associated metabolic complications display sexual dimorphism and can be impacted by cytokines. We previously showed that interleukin-10 (IL-10) was upregulated in white adipose tissue (WAT) of obese women with type 2 diabetes (T2D). Whether this pertains to men is unknown. The aim of this study was to compare the impact of obesity and T2D on WAT IL-10 levels in men versus women. Methods: Plasma and subcutaneous WAT biopsies were obtained from 108 metabolically well-characterized individuals. WAT IL10 expression/secretion and WAT-resident IL-10-secreting macrophage number were measured. Circulating sex hormone levels were correlated to WAT IL10 expression in 22 individuals and sex hormone effects on macrophage IL10 expression were investigated in vitro. Results: Obese women with T2D showed increased IL10 expression/secretion and IL-10-secreting WAT macrophage number compared to other female groups. This difference was absent in men. Non-obese women and men with T2D showed similar IL-10 levels compared to healthy controls, indicating that T2D alone does not regulate IL-10. Although WAT IL10 expression correlated with serum estrone (E1) concentrations, recombinant E1 did not affect macrophage IL10 expression in vitro. Conclusion: WAT IL-10 levels are higher in women with obesity and T2D, but not in men and this effect is primarily attributed to obesity per se. This is less likely to be driven by circulating sex hormones. We propose that the WAT IL-10 might exert protective effects in obesity-associated chronic inflammation in women which could be one of the contributing factors for the decreased morbidity observed in women during obesity than men.

OriginalsprogEngelsk
Artikelnummer996954
TidsskriftFrontiers in Endocrinology
Vol/bind13
ISSN1664-2392
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
Swedish research council (2016-00694), Novo Nordisk Foundation including NNF210C0069989, the Tripartite Immuno-metabolism Consortium (TrIC) Grant Number NNF15CC0018486 and the MSAM consortium NNF15SA0018346 and the Strategic Research Programme in Diabetes at Karolinska Institutet, KID grant at Karolinska Institutet.

Publisher Copyright:
Copyright © 2022 Subramanian, Tavira, Hofwimmer, Gutsmann, Massier, Abildgaard, Juul, Rydén, Arner and Laurencikiene.

ID: 324903239